These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 16403823

  • 1. Improvement of cardiac performance and cardiovascular risk factors in children with GH deficiency after two years of GH replacement therapy: an observational, open, prospective, case-control study.
    Salerno M, Esposito V, Farina V, Radetti G, Umbaldo A, Capalbo D, Spinelli L, Muzzica S, Lombardi G, Colao A.
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1288-95. PubMed ID: 16403823
    [Abstract] [Full Text] [Related]

  • 2. Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy.
    Salerno M, Esposito V, Spinelli L, Di Somma C, Farina V, Muzzica S, de Horatio LT, Lombardi G, Colao A.
    Clin Endocrinol (Oxf); 2004 May; 60(5):630-6. PubMed ID: 15104568
    [Abstract] [Full Text] [Related]

  • 3. Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency.
    Colao A, Di Somma C, Cuocolo A, Spinelli L, Acampa W, Spiezia S, Rota F, Savanelli MC, Lombardi G.
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5146-55. PubMed ID: 15985481
    [Abstract] [Full Text] [Related]

  • 4. The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study.
    Colao A, di Somma C, Pivonello R, Cuocolo A, Spinelli L, Bonaduce D, Salvatore M, Lombardi G.
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1088-93. PubMed ID: 11889170
    [Abstract] [Full Text] [Related]

  • 5. Three weekly injections (TWI) of low-dose growth hormone (GH) restore low normal circulating IGF-I concentrations and reverse cardiac abnormalities associated with adult onset GH deficiency (GHD).
    Pincelli AI, Bragato R, Scacchi M, Branzi G, Osculati G, Viarengo R, Leonetti G, Cavagnini F.
    J Endocrinol Invest; 2003 May; 26(5):420-8. PubMed ID: 12906369
    [Abstract] [Full Text] [Related]

  • 6. The cardiovascular risk of GH-deficient adolescents.
    Colao A, Di Somma C, Salerno M, Spinelli L, Orio F, Lombardi G.
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3650-5. PubMed ID: 12161490
    [Abstract] [Full Text] [Related]

  • 7. Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency.
    Colao A, di Somma C, Cuocolo A, Spinelli L, Tedesco N, Pivonello R, Bonaduce D, Salvatore M, Lombardi G.
    J Clin Endocrinol Metab; 2001 May; 86(5):1874-81. PubMed ID: 11344175
    [Abstract] [Full Text] [Related]

  • 8. Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.
    Esposito V, Di Biase S, Lettiero T, Labella D, Simeone R, Salerno M.
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):607-11. PubMed ID: 15521964
    [Abstract] [Full Text] [Related]

  • 9. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
    Lanes R, Gunczler P, Lopez E, Esaa S, Villaroel O, Revel-Chion R.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of left ventricular mass and function, lipid profile, and insulin resistance in Egyptian children with growth hormone deficiency: A single-center prospective case-control study.
    Metwalley KA, Farghaly HS, Abd El-Hafeez HA.
    Indian J Endocrinol Metab; 2013 Sep; 17(5):876-82. PubMed ID: 24083170
    [Abstract] [Full Text] [Related]

  • 11. Cardiac mass and function, carotid artery intima media thickness, homocysteine and lipoprotein levels in children and adolescents with growth hormone deficiency.
    Szczepańiska Kostro J, Tołwińska J, Urban M, Gardziejczyk M, Głowińska B.
    J Pediatr Endocrinol Metab; 2004 Oct; 17(10):1405-13. PubMed ID: 15526719
    [Abstract] [Full Text] [Related]

  • 12. Subtle alterations of cardiac performance in children with growth hormone deficiency: results of a two-year prospective, case-control study.
    Capalbo D, Lo Vecchio A, Farina V, Spinelli L, Palladino A, Tiano C, Lettiero T, Lombardi G, Colao A, Salerno M.
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3347-55. PubMed ID: 19584193
    [Abstract] [Full Text] [Related]

  • 13. Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency.
    Ciresi A, Amato MC, Criscimanna A, Mattina A, Vetro C, Galluzzo A, D'Acquisto G, Giordano C.
    Eur J Endocrinol; 2007 Mar; 156(3):353-60. PubMed ID: 17322495
    [Abstract] [Full Text] [Related]

  • 14. Cross-sectional and prospective study of the effects of GH therapy on metabolic panel in children with GH deficiency.
    Ramistella V, Wasniewska M, Arasi S, Catena M, Velletri MR, Corica D, Santucci S, De Luca F.
    Pediatr Med Chir; 2014 Dec 30; 36(5-6):104. PubMed ID: 25669895
    [Abstract] [Full Text] [Related]

  • 15. Effects of one year of recombinant human growth hormone (GH) therapy on cardiac mass and function in children with classical GH deficiency.
    Shulman DI, Root AW, Diamond FB, Bercu BB, Martinez R, Boucek RJ.
    J Clin Endocrinol Metab; 2003 Sep 30; 88(9):4095-9. PubMed ID: 12970269
    [Abstract] [Full Text] [Related]

  • 16. Impaired cardiac performance in elderly patients with growth hormone deficiency.
    Colao A, Cuocolo A, Di Somma C, Cerbone G, Della Morte AM, Nicolai E, Lucci R, Salvatore M, Lombardi G.
    J Clin Endocrinol Metab; 1999 Nov 30; 84(11):3950-5. PubMed ID: 10566633
    [Abstract] [Full Text] [Related]

  • 17. Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia.
    Follin C, Thilén U, Ahrén B, Erfurth EM.
    J Clin Endocrinol Metab; 2006 May 30; 91(5):1872-5. PubMed ID: 16522695
    [Abstract] [Full Text] [Related]

  • 18. The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis.
    Colao A, Di Somma C, Spiezia S, Rota F, Pivonello R, Savastano S, Lombardi G.
    J Clin Endocrinol Metab; 2006 Jun 30; 91(6):2191-200. PubMed ID: 16537686
    [Abstract] [Full Text] [Related]

  • 19. [Left ventricular mass and function in growth hormone deficient children and adolescents before and after one year of recombinant human growth hormone (GH) replacement therapy].
    Szczepańska Kostro J, Tołwińska J, Urban M, Głowińska B.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004 Jun 30; 10(2):75-80. PubMed ID: 15504309
    [Abstract] [Full Text] [Related]

  • 20. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
    Minczykowski A, Gryczynska M, Ziemnicka K, Czepczynski R, Sowinski J, Wysocki H.
    Growth Horm IGF Res; 2005 Apr 30; 15(2):156-64. PubMed ID: 15809020
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.